VANCOUVER, British Columbia–(BUSINESS WIRE)–eSense Health Inc. is proud to announce the publication of a pivotal randomized clinical trial in the peer-reviewed journal Behaviour Research & Therapy, validating the efficacy of its flagship product, eSense—a digital program designed to support women experiencing Female Sexual Interest/Arousal Disorder (SIAD), a condition that affects up to 40% of women. Sexual concerns such as low desire, arousal challenges, and discomfort during intimacy ar
Home › Businesswire Feed › Pivotal Study Confirms eSense as Effective Digital Program for Women’s Sexual Health